#45 Clinical Context
Background information relevant to the evolving cannabis medicine landscape.
Even CBD products labeled ‘THC-free’ may contain trace amounts that violate the new rules, which means the product you trust for wellness could be pulled from shelves.
Analysis warns that even CBD products labeled ‘THC-free’ could be impacted if testing reveals minimal THC or synthesized cannabinoids. States like Texas and Kentucky, with robust hemp industries but no recreational programs, may bear the brunt. A 2023 study found CBD products frequently contained small THC amounts even when claiming otherwise. NORML’s Paul Armentano called the approach ‘a sledgehammer when they should have used a scalpel.’ Regulation is preferable to an outright ban.
“When your regulatory framework is so blunt that it threatens to ban products with virtually no THC, you haven’t written a safety law,you’ve written a prohibition law.”
THE FARM BILL CLOCK: WHAT COMES AFTER THE 2024 EXTENSION
The 2024 Farm Bill extension bought time, but it also started a countdown. The modified hemp provisions take effect November 2026, and the window for Congressional action is narrowing.
Here’s the legislative landscape:
The HEMP Act (introduced February 2, 2026) proposes a comprehensive federal framework for hemp-derived cannabinoids, including product safety standards, age restrictions, and regulatory pathways. It has bipartisan support but faces opposition from both the marijuana industry (which sees hemp cannabinoids as unfair competition) and anti-drug groups.
Senator Ron Wyden and Representative Earl Blumenauer are pushing amendments that would preserve the 2018 Farm Bill’s hemp definition while adding consumer protection guardrails. Their approach treats hemp cannabinoids as food/supplement products rather than controlled substances.
The December 2025 Executive Order directed agencies to ‘minimize disruption’ to the hemp industry, but executive orders can’t override statute. The order’s practical effect has been to delay aggressive enforcement planning, not to change the law.
Timeline reality check: Congress needs to pass legislation before November 2026. Given the typical pace of cannabis-related legislation, this is ambitious. The most realistic path is an amendment to the next appropriations bill or a standalone hemp reform bill that can attract enough bipartisan support to clear both chambers.
The industry’s best strategy: aggressive lobbying through spring and summer, with a fallback plan for state-level advocacy if federal reform stalls.
Have thoughts on this? Share it:
๐ฌ Join the Conversation
Have a question about how this applies to your situation? Ask Dr. Caplan โ
Want to discuss this topic with other patients and caregivers? Join the forum discussion โ